Oxidative Stress: A Unifying Paradigm in Hypertension

Canadian Journal of Cardiology - Tập 36 Số 5 - Trang 659-670 - 2020
Rhian M. Touyz1, Francisco J. Rios1, Rhéure Alves-Lopes1, Karla B Neves1, Lívia L. Camargo1, Augusto C. Montezano1
1Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, United Kingdom

Tóm tắt

Từ khóa


Tài liệu tham khảo

Oparil, 2018, Hypertension, Nat Rev Dis Primers, 4, 18014, 10.1038/nrdp.2018.14

Harrison, 2013, The mosaic theory revisited: common molecular mechanisms coordinating diverse organ and cellular events in hypertension, J Am Soc Hypertens, 7, 68, 10.1016/j.jash.2012.11.007

Harvey, 2015, Vascular biology of ageing—implications in hypertension, J Mol Cell Cardiol, 8, 112, 10.1016/j.yjmcc.2015.04.011

Stanley, 2019, Singlet molecular oxygen regulates vascular tone and blood pressure in inflammation, Nature, 5, 548, 10.1038/s41586-019-0947-3

Knock, 2019, NADPH oxidase in the vasculature: expression, regulation and signalling pathways; role in normal cardiovascular physiology and its dysregulation in hypertension, Free Radic Biol Med, 1, 385, 10.1016/j.freeradbiomed.2019.09.029

Lassegue, 2003, Vascular NAD(P)H oxidases: specific features, expression, and regulation, Am J Physiol Regul Integr Comp Physiol, 2, R277, 10.1152/ajpregu.00758.2002

Montezano, 2011, Novel Nox homologues in the vasculature: focusing on Nox4 and Nox5, Clin Sci (Lond), 1, 131, 10.1042/CS20100384

Touyz, 2001, Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D–dependent NAD(P)H oxidase–sensitive pathways, J Hypertens, 1, 1245, 10.1097/00004872-200107000-00009

Zhang, 2020, NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets, Nat Rev Cardiol, 17, 170, 10.1038/s41569-019-0260-8

Dikalova, 2010, Therapeutic targeting of mitochondrial superoxide in hypertension, Circ, 1, 106

Dikalov, 2014, Nox2-induced production of mitochondrial superoxide in angiotensin II–mediated endothelial oxidative stress and hypertension, Antioxid Redox Signal, 2, 281, 10.1089/ars.2012.4918

Carlisle, 2016, Endoplasmic reticulum stress inhibition reduces hypertension through the preservation of resistance blood vessel structure and function, J Hypertens, 3, 1556, 10.1097/HJH.0000000000000943

Zinkevich, 2011, ROS-induced ROS release in vascular biology: redox-redox signaling, Am J Physiol, 3, H647

Koju, 2019, Pharmacological strategies to lower crosstalk between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and mitochondria, Biomed Pharmacother, 1, 1478, 10.1016/j.biopha.2018.11.128

He, 2019, Inhibition of mitochondrial oxidative damage improves reendothelialization capacity of endothelial progenitor cells via SIRT3 (Sirtuin 3)–enhanced SOD2 (superoxide dismutase 2) deacetylation in hypertension, Arterioscler Thromb Vasc Biol, 3, 1682, 10.1161/ATVBAHA.119.312613

Rossman, 2018, Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults, Hypertension, 7, 1056, 10.1161/HYPERTENSIONAHA.117.10787

Chan, 2017, Mitochondria and reactive oxygen species contribute to neurogenic hypertension, Physiology (Bethesda), 3, 308

Camargo, 2018, Vascular Nox (NADPH oxidase) compartmentalization, protein hyperoxidation, and endoplasmic reticulum stress response in hypertension, Hypertension, 7, 235, 10.1161/HYPERTENSIONAHA.118.10824

Lushchak, 2014, Free radicals, reactive oxygen species, oxidative stress and its classification, Chem Biol Interact, 2, 164, 10.1016/j.cbi.2014.10.016

Sies, 2017, Oxidative stress, Annu Rev Biochem, 8, 715, 10.1146/annurev-biochem-061516-045037

Lichtenberg, 2015, Oxidative stress, the term and the concept, Biochem Biophys Res Commun, 4, 441, 10.1016/j.bbrc.2015.04.062

Sies, 2017, Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress, Redox Biol, 1, 613, 10.1016/j.redox.2016.12.035

Sies, 2018, On the history of oxidative stress: concept and some aspects of current development, Curr Opin Toxic, 7, 122, 10.1016/j.cotox.2018.01.002

Furchgott, 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 2, 373, 10.1038/288373a0

Ignarro, 1988, Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation, J Pharmacol Exp Ther, 2, 181

Ferrer-Sueta, 2018, Biochemistry of peroxynitrite and protein tyrosine nitration, Chem Rev, 1, 1338, 10.1021/acs.chemrev.7b00568

Incalza, 2018, Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases, Vascul Pharmacol, 1, 1, 10.1016/j.vph.2017.05.005

Baba, 2018, Role of thiols in oxidative stress, Curr Opin Toxicol, 7, 133, 10.1016/j.cotox.2018.03.005

Hawkins, 2019, Detection, identification, and quantification of oxidative protein modifications, J Biol Chem, 2, 19683, 10.1074/jbc.REV119.006217

Griendling, 2016, Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the American Heart Association, Circ Res, 1, 39

Skoko, 2019, Signals getting crossed in the entanglement of redox and phosphorylation pathways: phosphorylation of peroxiredoxin proteins sparks cell signaling, Antioxidants (Basel), 8, 29, 10.3390/antiox8020029

Wenzel, 2017, Redox regulation of cardiovascular inflammation—immunomodulatory function of mitochondrial and Nox-derived reactive oxygen and nitrogen species, Free Radic Biol Med, 1, 48, 10.1016/j.freeradbiomed.2017.01.027

Hood, 2016, Nicotinamide adenine dinucleotide phosphate oxidase–mediated redox signaling and vascular remodeling by 16α-hydroxyestrone in human pulmonary artery cells: implications in pulmonary arterial hypertension, Hypertension, 6, 796, 10.1161/HYPERTENSIONAHA.116.07668

Vukelic, 2014, Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift, Circ Res, 1, 754, 10.1161/CIRCRESAHA.114.303045

Ray, 2012, Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling, Cell Signal, 2, 981, 10.1016/j.cellsig.2012.01.008

García-Redondo, 2015, c-Src, ERK1/2 and Rho kinase mediate hydrogen peroxide-induced vascular contraction in hypertension: role of TXA2, NAD(P)H oxidase and mitochondria, J Hypertens, 3, 77, 10.1097/HJH.0000000000000383

Wei, 2014, Regulation of bone morphogenetic protein 9 (BMP9) by redox-dependent proteolysis, J Biol Chem, 2, 31150, 10.1074/jbc.M114.579771

Tabet, 2005, Mitogen-activated protein kinase activation by hydrogen peroxide is mediated through tyrosine kinase–dependent, protein kinase C–independent pathways in vascular smooth muscle cells: upregulation in spontaneously hypertensive rats, J Hypertens, 2, 2005, 10.1097/01.hjh.0000185715.60788.1b

Go, 2011, Cysteine/cystine redox signaling in cardiovascular disease, Free Radic Biol Med, 5, 495, 10.1016/j.freeradbiomed.2010.11.029

Cuello, 2018, Oxidation of cardiac myofilament proteins: priming for dysfunction?, Mol Aspects Med, 6, 47, 10.1016/j.mam.2018.08.003

Paravicini, 2006, Redox signaling in hypertension, Cardiovasc Res, 7, 247, 10.1016/j.cardiores.2006.05.001

Cuadrado, 2018, Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach, Pharmacol Rev, 7, 348, 10.1124/pr.117.014753

Brautigan, 2018, Protein serine/threonine phosphatases: keys to unlocking regulators and substrates, Annu Rev Biochem, 8, 921, 10.1146/annurev-biochem-062917-012332

Tabet, 2008, Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR, Circ Res, 1, 149, 10.1161/CIRCRESAHA.108.178608

Tejero, 2019, Sources of vascular nitric oxide and reactive oxygen species and their regulation, Physiol Rev, 9, 311, 10.1152/physrev.00036.2017

Freed, 2017, Communication is key: mechanisms of intercellular signaling in vasodilation, J Cardiovasc Pharmacol, 6, 264, 10.1097/FJC.0000000000000463

Feelisch, 2020, Long-lasting blood pressure lowering effects of nitrite are NO-independent and mediated by hydrogen peroxide, persulfides, and oxidation of protein kinase G1α redox signalling, Cardiovasc Res, 1, 51, 10.1093/cvr/cvz202

Friederich-Persson, 2017, Brown adipose tissue regulates small artery function through NADPH oxidase 4–derived hydrogen peroxide and redox-sensitive protein kinase G-1α, Arterioscler Thromb Vasc Biol, 3, 455, 10.1161/ATVBAHA.116.308659

Kim, 2017, ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis, Am J Physiol Cell Physiol, 3, C749, 10.1152/ajpcell.00346.2016

Knock, 2011, Redox regulation of protein kinases as a modulator of vascular function, Antioxid Redox Signal, 1, 1531, 10.1089/ars.2010.3614

Cameron, 2015, Polarized cell motility induces hydrogen peroxide to inhibit cofilin via cysteine oxidation, Curr Biol, 2, 1520, 10.1016/j.cub.2015.04.020

Dikalov, 2013, Role of mitochondrial oxidative stress in hypertension, Am J Physiol Heart Circ Physiol, 3, H1417, 10.1152/ajpheart.00089.2013

Araujo, 2014, Oxidative stress in hypertension: role of the kidney, Antioxid Redox Signal, 2, 74, 10.1089/ars.2013.5259

Callera, 2006, Endothelin-1–induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase–independent mechanisms, Clin Sci (Lond), 1, 243, 10.1042/CS20050307

Vaka, 2020, Blockade of endogenous angiotensin II type I receptor agonistic autoantibody activity improves mitochondrial reactive oxygen species and hypertension in a rat model of preeclampsia, Am J Physiol Regul Integr Comp Physiol, 3, R256, 10.1152/ajpregu.00179.2019

Sánchez-Aranguren, 2014, Endothelial dysfunction and preeclampsia: role of oxidative stress, Front Physiol, 5, 372, 10.3389/fphys.2014.00372

Lopes, 2015, Downregulation of nuclear factor erythroid 2-related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension, Hypertension, 6, 1240, 10.1161/HYPERTENSIONAHA.115.06163

Drummond, 2011, Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets, Nat Rev Drug Discov, 1, 453, 10.1038/nrd3403

Cifuentes-Pagano, 2012, NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS, Cell Mol Life Sci, 6, 2315, 10.1007/s00018-012-1009-2

Maksimenko, 2005, Experimental antioxidant biotherapy for protection of the vascular wall by modified forms of superoxide dismutase and catalase, Curr Pharm Des, 1, 2007, 10.2174/1381612054065756

Gomez-Guzman, 2012, Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension, Free Rad Biol Med, 5, 70, 10.1016/j.freeradbiomed.2011.09.015

Touyz, 2017, Redox stress defines the small artery vasculopathy of hypertension: how do we bridge the bench-to-bedside gap?, Circ Res, 1, 1721, 10.1161/CIRCRESAHA.117.310672

Montezano, 2015, Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies, Can J Cardiol, 3, 631, 10.1016/j.cjca.2015.02.008

Ward, 2004, Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle, Free Radic Biol Med, 3, 226, 10.1016/j.freeradbiomed.2003.10.021

Ghasemzadeh, 2014, Oxidative stress is associated with increased pulmonary artery systolic pressure in humans, Hypertension, 6, 1270, 10.1161/HYPERTENSIONAHA.113.02360

Verma, 2019, Oxidative stress and biomarker of TNF-α, MDA and FRAP in hypertension, J Med Life, 1, 253

Gkaliagkousi, 2018, Asymmetric dimethylarginine levels are associated with augmentation index across naïve untreated patients with different hypertension phenotypes, J Clin Hypertens (Greenwich), 2, 680, 10.1111/jch.13237

Carrizzo, 2013, Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism, Hypertension, 6, 359, 10.1161/HYPERTENSIONAHA.111.01009

González, 2014, Essential hypertension and oxidative stress: new insights, World J Cardiol, 6, 353, 10.4330/wjc.v6.i6.353

Touyz, 2005, p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P)H oxidase regulation by angiotensin II, Arterioscler Thromb Vasc Biol, 2, 512, 10.1161/01.ATV.0000154141.66879.98

Young, 2017, Endoplasmic reticulum stress in the pathogenesis of hypertension, Exp Physiol, 1, 869, 10.1113/EP086274

Santos, 2014, Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension, Antioxid Redox Signal, 20, 121, 10.1089/ars.2013.5262

Rodrigo, 2013, Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage, Dis Markers, 3, 773, 10.1155/2013/974358

Eslami, 2014, Glutathione-S-transferase M1 and T1 null genotypes are associated with hypertension risk: a systematic review and meta-analysis of 12 studies, Curr Hypertens Rep, 1, 43

Wyche, 2004, C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils, Hypertension, 4, 1246, 10.1161/01.HYP.0000126579.50711.62

Rafiq, 2014, C242T polymorphism of the NADPH oxidase p22PHOX gene and its association with endothelial dysfunction in asymptomatic individuals with essential systemic hypertension, Mol Med Rep, 9, 1857, 10.3892/mmr.2014.1992

Kraja, 2017, New blood pressure-associated loci identified in meta-analyses of 475 000 individuals, Circ Cardiovasc Genet, 10, 10.1161/CIRCGENETICS.117.001778

Sylvester, 2019, Sex-specific mechanisms in inflammation and hypertension, Curr Hypertens Rep, 2, 53, 10.1007/s11906-019-0959-2

Ji, 2010, Sex chromosome effects unmasked in Ang II–induced hypertension, Hypertension, 5, 1275, 10.1161/HYPERTENSIONAHA.109.144949

Khan, 2019, Chin-Dusting JPF. Y chromosome, hypertension and cardiovascular disease: is inflammation the answer?, Int J Mol Sci, 20, 2892, 10.3390/ijms20122892

Ojeda, 2014, Sex differences in the developmental programming of hypertension, Acta Physiol (Oxf), 2, 307, 10.1111/apha.12206

Reckelhoff, 2019, Sex, oxidative stress, and hypertension: Insights from animal models, Physiology (Bethesda), 3, 178

Ide, 2002, Greater oxidative stress in healthy young men compared with premenopausal women, Arterioscler Thromb Vasc Biol, 2, 1239

Bhatia, 2012, Oxidative stress contributes to sex differences in angiotensin II–mediated hypertension in spontaneously hypertensive rats, Am J Physiol Regul Integr Comp Physiol, 3, R274, 10.1152/ajpregu.00546.2011

Ji, 2007, Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production, Gend Med, 4, 56, 10.1016/S1550-8579(07)80009-X

Miller, 2007, Effect of gender on NADPH-oxidase activity, expression and function in the cerebral circulation: role of estrogen, Stroke, 3, 2142, 10.1161/STROKEAHA.106.477406

Borras, 2005, 17Beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK-1 and ERK2(MAPK)/NFκB cascade, Aging Cell, 4, 113, 10.1111/j.1474-9726.2005.00151.x

Nguyen Dinh Cat, 2013, Angiotensin II, NADPH oxidase, and redox signaling in the vasculature, Antioxid Redox Signal, 1, 1110, 10.1089/ars.2012.4641

Montezano, 2014, Angiotensin II and vascular injury, Curr Hypertens Rep, 1, 431, 10.1007/s11906-014-0431-2

Guzik, 2017, Oxidative stress, inflammation, and vascular aging in hypertension, Hypertension, 7, 660, 10.1161/HYPERTENSIONAHA.117.07802

Petrie, 2018, Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms, Can J Cardiol, 3, 575, 10.1016/j.cjca.2017.12.005

Masi, 2019, Angiotensin II and vascular damage in hypertension: Role of oxidative stress and sympathetic activation, Vascul Pharmacol, 1, 13, 10.1016/j.vph.2019.01.004

Mattson, 2019, Immune mechanisms of salt-sensitive hypertension and renal end-organ damage, Nat Rev Nephrol, 1, 290, 10.1038/s41581-019-0121-z

Rajagopalan, 2018, Air pollution and cardiovascular disease: JACC state-of-the-art review, J Am Coll Cardiol, 7, 2054, 10.1016/j.jacc.2018.07.099

Rautureau, 2012, Endothelin in hypertension: an update, Curr Opin Nephrol Hypertens, 2, 128, 10.1097/MNH.0b013e32834f0092

Touyz, 2018, Vascular smooth muscle contraction in hypertension, Cardiovasc Res, 1, 529, 10.1093/cvr/cvy023

Lopes, 2020, Crosstalk between vascular redox and calcium signaling in hypertension involves TRPM2 (transient receptor potential melastatin 2) cation channel, Hypertension, 7, 139, 10.1161/HYPERTENSIONAHA.119.13861

Mihalj, 2016, Blood pressure reduction is associated with the changes in oxidative stress and endothelial activation in hypertension, regardless of antihypertensive therapy, Kidney Blood Press Res, 4, 721, 10.1159/000450562

Xu, 2009, Endothelial cells negatively modulate reactive oxygen species generation in vascular smooth muscle cells: role of thioredoxin, Hypertension, 5, 427, 10.1161/HYPERTENSIONAHA.109.133983

Dikalov, 2014, Nox2-induced production of mitochondrial superoxide in angiotensin II–mediated endothelial oxidative stress and hypertension, Antioxid Redox Signal, 2, 281, 10.1089/ars.2012.4918

Coelho, 2018, Three-month endothelial human endothelin-1 overexpression causes blood pressure elevation and vascular and kidney injury, Hypertension, 7, 208, 10.1161/HYPERTENSIONAHA.117.09925

Tsai, 2017, Enhanced endothelin-1/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy, Cardiovasc Res, 1, 1329, 10.1093/cvr/cvx103

Colafella KM, Neves KB, Montezano AC, et al. Selective ETA versus dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats [e-pub ahead of print]. Cardiovasc Res.

Ganesh, 2016, Impact of superoxide dismutase mimetic AEOL 10150 on the endothelin system of Fischer 344 rats, PLoS One, 1

du Plooy, 2017, The association of endothelin-1 with markers of oxidative stress in a biethnic South African cohort: the SABPA study, Hypertens Res, 4, 189, 10.1038/hr.2016.128

Fernandez-Patron, 2007, Therapeutic potential of the epidermal growth factor receptor transactivation in hypertension: a convergent signaling pathway of vascular tone, oxidative stress, and hypertrophic growth downstream of vasoactive G-protein–coupled receptors?, Can J Physiol Pharmacol, 8, 97, 10.1139/y06-097

Forrester, 2018, Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology, Physiol Rev, 9, 1627, 10.1152/physrev.00038.2017

Neves, 2018, VEGFR (vascular endothelial growth factor receptor) inhibition induces cardiovascular damage via redox-sensitive processes, Hypertension, 7, 638, 10.1161/HYPERTENSIONAHA.117.10490

Li, 2010, Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR, Am J Physiol Heart Circ Physiol, 2, H1959, 10.1152/ajpheart.00526.2010

Cruzado, 2005, Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation, Am J Hypertens, 1, 81, 10.1016/j.amjhyper.2004.09.001

Touyz, 2003, Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation, Can J Physiol Pharmacol, 8, 159, 10.1139/y02-164

Touyz, 2002, Increased angiotensin II–mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats, Hypertension, 3, 479, 10.1161/hy02t2.102909

Dinh, 2017, Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress, Aging (Albany NY), 9, 1595, 10.18632/aging.101255

Zahradka, 2004, Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase, Endocrinology, 1, 2978, 10.1210/en.2004-0029

Montezano, 2015, Redox signaling, Nox5 and vascular remodeling in hypertension, Curr Opin Nephrol Hypertens, 2, 425, 10.1097/MNH.0000000000000153

Pantelidis, 2018, The mechanisms of actions of aldosterone and its antagonists in cardiovascular disease, Curr Pharm Des, 2, 5491

Cannavo, 2018, Aldosterone and mineralocorticoid receptor system in cardiovascular physiology and pathophysiology, Oxid Med Cell Longev, 20, 1204598

Chou, 2018, IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis, Cardiovasc Res, 1, 690, 10.1093/cvr/cvy013

Rossi, 2019, Primary aldosteronism: JACC state-of-the-art review, J Am Coll Cardiol, 7, 2799, 10.1016/j.jacc.2019.09.057

Kawarazaki, 2016, The role of aldosterone in obesity-related hypertension, Am J Hypertens, 2, 415, 10.1093/ajh/hpw003

Funder, 2019, Primary aldosteronism, Hypertension, 7, 458, 10.1161/HYPERTENSIONAHA.119.12935

Virdis, 2002, Spironolactone improves angiotensin-induced vascular changes and oxidative stress, Hypertension, 4, 504, 10.1161/01.HYP.0000034738.79310.06

Beswick, 2001, NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat, Hypertension, 3, 1107, 10.1161/hy1101.093423

McCurley, 2012, Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors, Nat Med, 1, 1429, 10.1038/nm.2891

Briet, 2016, Aldosterone-induced vascular remodeling and endothelial dysfunction require functional angiotensin type 1a receptors, Hypertension, 6, 897, 10.1161/HYPERTENSIONAHA.115.07074

Montezano, 2008, Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src–regulated redox-sensitive RhoA pathways, Arterioscler Thromb Vasc Biol, 2, 1511, 10.1161/ATVBAHA.108.168021

Fan, 2008, Synergy of aldosterone and high salt induces vascular smooth muscle hypertrophy through up-regulation of NOX1, J Steroid Biochem Mol Biol, 1, 29, 10.1016/j.jsbmb.2008.02.012

Iwashima, 2008, Aldosterone induces superoxide generation via Rac1 activation in endothelial cells, Endocrinology, 1, 1009, 10.1210/en.2007-0864

Harvey, 2017, Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: the aldosterone–mineralocorticoid receptor–Nox1 axis, Life Sci, 1, 110, 10.1016/j.lfs.2017.05.002

Hashikabe, 2006, Aldosterone impairs vascular endothelial cell function, J Cardiovasc Pharmacol, 4, 609, 10.1097/01.fjc.0000211738.63207.c3

Callera, 2005, c-Src–dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats, Hypertension, 4, 1032, 10.1161/01.HYP.0000176588.51027.35

Rautureau, 2011, Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells, Steroids, 7, 834

Cannavo, 2016, Myocardial pathology induced by aldosterone is dependent on noncanonical activities of G protein-coupled receptor kinases, Nat Commun, 7, 10877, 10.1038/ncomms10877

Silva, 2015, Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling, Front Physiol, 6, 269, 10.3389/fphys.2015.00269

Nakano, 2005, Hypertens Res, 2, 925, 10.1291/hypres.28.925

Nguyen Dinh Cat, 2010, The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure, FASEB J, 2, 2454

Favre, 2011, Coronary endothelial dysfunction after cardiomyocyte-specific mineralocorticoid receptor overexpression, Am J Physiol Heart Circ Physiol, 3, H2035, 10.1152/ajpheart.00552.2010

Ahokas, 2003, Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface, Circ Res, 9, e124

Bienvenu, 2012, Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis, Endocrinology, 1, 3416, 10.1210/en.2011-2098

Hirata, 2012, Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction, Biochem Biophys Res Commun, 4, 182, 10.1016/j.bbrc.2012.01.139

Ross, 1993, The pathogenesis of atherosclerosis: a perspective for the 1990, Nature, 3, 801, 10.1038/362801a0

Barrows, 2019, Inflammation, immunity, and oxidative stress in hypertension—partners in crime?, Adv Chronic Kidney Dis, 2, 122, 10.1053/j.ackd.2019.03.001

Tomiyama, 2017, The contribution of inflammation to the development of hypertension mediated by increased arterial stiffness, J Am Heart Assoc, 6

Carbone, 2019, Baseline hs-CRP predicts hypertension remission in metabolic syndrome, Eur J Clin Invest, 4, e13128, 10.1111/eci.13128

Schüler, 2019, T cell–derived IL-17A induces vascular dysfunction via perivascular fibrosis formation and dysregulation of •NO/cGMP signaling, Oxid Med Cell Longev, 20, 6721531

Burger, 2011, Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/Rho kinase pathways targeted to lipid rafts, Arterioscler Thromb Vasc Biol, 3, 1898, 10.1161/ATVBAHA.110.222703

Norlander, 2018, The immunology of hypertension, J Exp Med, 2, 21, 10.1084/jem.20171773

Schiffrin, 2015, Mechanisms of remodeling of small arteries, antihypertensive therapy and the immune system in hypertension, Clin Invest Med, 3, 394, 10.25011/cim.v38i6.26202

Harijith, 2014, Reactive oxygen species at the crossroads of inflammasome and inflammation, Front Physiol, 5, 10.3389/fphys.2014.00352

Pasqua, 2018, Role of NLRP 3 inflammasome in hypertension: A potential therapeutic target, Curr Pharm Biotechnol, 1, 708, 10.2174/1389201019666180808162011

Zhong, 2013, TRPM2 links oxidative stress to NLRP3 inflammasome activation, Nat Commun, 4, 1611, 10.1038/ncomms2608

Zhang, 2019, NLRP3 inflammasome is involved in calcium-sensing receptor–induced aortic remodeling in SHRs, Mediators Inflamm, 20, 6847087

Villegas, 2013, Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome, Antioxid Redox Signal, 1, 1753, 10.1089/ars.2012.4799

Ferreira, 2019, NLRP3 inflammasome and mineralocorticoid receptors are associated with vascular dysfunction in type 2 diabetes mellitus, Cells, 8, 1595, 10.3390/cells8121595

Guzik, 2007, Role of the T cell in the genesis of angiotensin ii induced hypertension and vascular dysfunction, J Exp Med, 2, 2449, 10.1084/jem.20070657

de Ciuceis, 2005, Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II–infused macrophage colony–stimulating factor–deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury, Arterioscler Thromb Vasc Biol, 2, 2106, 10.1161/01.ATV.0000181743.28028.57

Wenzel, 2019, Monocytes as immune targets in arterial hypertension, Br J Pharmacol, 1, 1966, 10.1111/bph.14389

Radi, 2018, Oxygen radicals, nitric oxide, and peroxynitrite: redox pathways in molecular medicine, Proc Natl Acad Sci U S A, 1, 5839, 10.1073/pnas.1804932115

Carracedo, 2018, Protein carbamylation: a marker reflecting increased age-related cell oxidation, Int J Mol Sci, 19, 1495, 10.3390/ijms19051495

Sheehan, 2019, The clinical potential of thiol redox proteomics, Expert Rev Proteomics, 2, 1